LFCR
What one share of Lifecore Biomedical holds
Pharmaceutical Preparations
Lifecore Biomedical, Inc. and its subsidiaries (“Lifecore”, the “Company”, “we” or “us”), located in Chaska, Minnesota, is a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated clinical and commercial capabilities in the development, cGMP manufacturing and aseptic filling of complex formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials and cartridges…
Lifecore Biomedical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Cash and investments | $0.46 |
|---|---|
| Debt | $4.27 |
| Book value | −$0.90 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $17.63 | −$0.43 | $1.47 | −$0.70 | — | $7.76 |
| 2017 | $16.99 | $0.38 | $0.83 | $0.25 | — | $8.24 |
| 2018 | $18.78 | $0.89 | $1.20 | −$0.49 | — | $9.12 |
| 2019 | $19.49 | $0.01 | $1.56 | −$1.00 | — | $9.28 |
| 2020 | $5.49 | −$1.31 | $0.42 | −$1.00 | — | $7.86 |
| 2021 | $3.44 | −$1.10 | $0.66 | −$0.10 | — | $6.88 |
| 2022 | $3.78 | −$3.96 | $0.89 | −$1.66 | — | $2.98 |
| 2023 | $3.45 | −$3.32 | — | −$0.58 | — | −$0.14 |
| 2024 | $3.50 | $0.33 | $0.50 | −$0.49 | — | $0.37 |
| 2025 | $3.70 | −$1.27 | $0.39 | −$0.39 | — | $0.04 |